{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:10:44Z","timestamp":1783012244449,"version":"3.54.6"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":216,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1111\/bjd.13307","type":"journal-article","created":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T05:03:40Z","timestamp":1406783020000},"page":"829-831","source":"Crossref","is-referenced-by-count":15,"title":["Rituximab in patients with recalcitrant autoimmune blistering diseases: experience in a cohort of 22 patients"],"prefix":"10.1093","volume":"172","author":[{"given":"D.","family":"Tomsitz","sequence":"first","affiliation":[{"name":"Klinik f\u00fcr Dermatologie; Venerologie und Allergologie; Charit\u00e9 Universit\u00e4tsmedizin Berlin; 10117 Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Stefaniak","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Dermatologie; Venerologie und Allergologie; Charit\u00e9 Universit\u00e4tsmedizin Berlin; 10117 Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Worm","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Dermatologie; Venerologie und Allergologie; Charit\u00e9 Universit\u00e4tsmedizin Berlin; 10117 Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,1,28]]},"reference":[{"key":"10.1111\/bjd.13307-BIB0001|bjd13307-cit-0001","first-page":"926","article-title":"Guidelines for the management of pemphigus vulgaris","volume":"149","author":"Harmann","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13307-BIB0002|bjd13307-cit-0002","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/bjd.12072","article-title":"British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012","volume":"167","author":"Venning","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13307-BIB0003|bjd13307-cit-0003","first-page":"727","article-title":"Efficacy and safety of rituximab in pemphigus: experience of the German Registry\u00a0of Autoimmune Diseases","volume":"10","author":"Kasperkiewicz","year":"2012","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/bjd.13307-BIB0004|bjd13307-cit-0004","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaad.2012.10.018","article-title":"Critical analysis of the use of rituximab in mucous membrane pemphigoid: a review of the literature","volume":"68","author":"Shetty","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13307-BIB0005|bjd13307-cit-0005","first-page":"672","article-title":"Treatment of bullous pemphigoid with rituximab: critical analysis of the current literature","volume":"12","author":"Shetty","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.13307-BIB0006|bjd13307-cit-0006","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/ard.2006.061002","article-title":"Consensus statement on the use of rituximab in patients with rheumatoid arthritis","volume":"66","author":"Smolen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/bjd.13307-BIB0007|bjd13307-cit-0007","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4103\/0378-6323.102354","article-title":"Rituximab in pemphigus","volume":"78","author":"Kanwar","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/bjd.13307-BIB0008|bjd13307-cit-0008","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000357031","article-title":"Pilot study of 19 patients with severe pemphigus: prophylactic treatment with rituximab does not appear to be beneficial","volume":"228","author":"Gregoriou","year":"2014","journal-title":"Dermatology"},{"key":"10.1111\/bjd.13307-BIB0009|bjd13307-cit-0009","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaci.2009.06.047","article-title":"Induction of long-lived allergen-specific plasma cells by mucosal allergen challenge","volume":"124","author":"Luger","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl. 3","key":"10.1111\/bjd.13307-BIB0010|bjd13307-cit-0010","doi-asserted-by":"crossref","first-page":"iii87","DOI":"10.1136\/ard.2008.098418","article-title":"How to cope with pathogenic long-lived plasma cells in autoimmune diseases","volume":"67","author":"Hoyer","year":"2008","journal-title":"Ann Rheum Dis"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.13307","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.13307\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:05:34Z","timestamp":1746320734000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/172\/3\/829\/6616132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,28]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.13307","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1,28]]}}}